Hukkelhoven Mathias has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 40000 shares of Centessa Pharmaceuticals plc ($CNTA) on June 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | Centessa Pharmaceuticals plc | $CNTA | Hukkelhoven Mathias | Director | A | Share Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 133,184,349 | 9999.99% | 0.03% |
| June 25, 2024 | Centessa Pharmaceuticals plc | $CNTA | Hukkelhoven Mathias | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Centessa Pharmaceuticals plc | $CNTA | Hukkelhoven Mathias | Director | A | Share Option (right to buy) | 48000 | $0.00 | 48,000.0000 | 0 | 9999.99% | 0.00% |